Objective. To define the natural history and outcome of eosinophilia-m
yalgia syndrome (EMS) among a cohort of patients followed up at one ce
nter since the onset of their disease. Methods. Fifty-seven patients w
ith well-characterized EMS were evaluated prospectively at a universit
y hospital for 21-64 months (mean 36 months). Results. Eighty-eight pe
rcent of the patients continue to have symptomatic disease with >3 cli
nical manifestations. Fatigue (91%), muscle cramping (75%), myalgia (7
0%), paresthesias with objectively demonstrated hypesthesias (62%), ar
ticular symptoms (54%), scleroderma-like skin changes (44%), and proxi
mal muscle weakness (40%) are the most common features of chronic EMS.
New findings identified among this cohort include cognitive symptoms
in 86% of the study group, tremor, and myoclonus. Conclusion. The reco
gnition of new manifestations in EMS and ongoing clinical disease in 8
8% of patients highlights the chronic nature of this disorder. Continu
ed prospective followup of a large patient base is warranted to furthe
r define the natural history of this newly recognized illness.